Minakem Generic APIs Minakem Generic APIs

X

Find the latest Drugs in Development and Pipeline Prospector News of Delic Corp.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Delic Corp
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Chicago, Illinois
Telephone
Telephone
(708) 515-4925

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

SPRAVATO® (esketamine) CIII nasal spray is a nonselective, noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptor – an ionotropic glutamate receptor.


Lead Product(s): Esketamine Hydrochloride

Therapeutic Area: Psychiatry/Psychology Product Name: Spravato

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Ketamine Wellness Center

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 01, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Ketamine treatments have successfully repaired and improved these connections while also building new, healthy ones. PTSD damage can reappear over time if the treatment is stopped and no other support strategies are put in place.


Lead Product(s): Ketamine Hydrochloride

Therapeutic Area: Psychiatry/Psychology Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Ketamine Wellness Centers

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership October 14, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY